Point72 Hong Kong LTD Regeneron Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $6.34 Million - $7.22 Million	8,184 New	8,184 $7.19 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $28,698 - $36,216	50 New	50 $34,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $1.96 Million - $2.3 Million	3,294 Added 427.24%	4,065 $2.84 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $1.47 Million - $1.81 Million	-2,702 Reduced 77.8%	771 $487,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1.83 Million - $2.17 Million	3,192 Added 1135.94%	3,473 $2.1 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $479,892 - $566,918	-1,015 Reduced 78.32%	281 $157,000
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $619,876 - $787,942	1,296 New	1,296 $626,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $171,675 - $224,084	-348 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $46,056 - $67,736	-137 Reduced 28.25%	348 $170,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $132,953 - $182,607	485 New	485 $182,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $40,745 - $56,415	-136 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $36,835 - $43,517	99 Added 267.57%	136 $56,000
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $12,425 - $14,912	37 New	37 $14,000
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $13,264 - $16,538	-42 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $15,062 - $19,737	42	42 $16,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.